Abstract Migraine is a highly prevalent headache disorder that has a substantial impact on the individual and society. Over the past decade, substantial advances in research have increased understanding of the pathophysiology, diagnosis, epidemiology, and treatment of the disorder. This article reviews the burden of migraine, emphasizing the population-based studies that used standardized diagnostic criteria.
Introduction
Headache disorders include a number of conditions characterized by recurrent episodes of head pain and associated symptoms. Though almost everyone gets occasional headaches, particular headache disorders vary in incidence, prevalence, and duration. Headache disorders are divided into the primary and secondary disorders. Secondary disorders have an identifiable underlying cause, such as an infection, a brain tumor, or stroke. In primary headache disorders, there is no apparent underlying cause [1, 2] .
Migraine is one of the most burdensome of the primary headache disorders [3] [4] [5] . The first population studies to apply the International Headache Society (IHS) criteria were conducted in Copenhagen; the population distribution of all headache disorders was examined using in-person clinical assessment in a large, representative community sample [4, 5] . The lifetime prevalences of various headache disorders from this population are summarized in Table 1 .
Tension-type headache is a far more common primary headache than migraine [4, 5] . Cluster headache is relatively uncommon, with a prevalence of 0.1% of this population [4, 5] . Of the secondary headaches, fasting S89 headache (a headache precipitated by missing meals) is the most common type, followed by the headache due to nose/sinus disease and headache secondary to head trauma. Nonvascular intracranial diseases, which include infections and brain tumors, were rare. For the rest of this review, we focus on migraine.
Migraine incidence and prevalence
Stewart et al. estimated migraine incidence using reported age of onset from a prevalence study [6, 7] . In males, the incidence of migraine with aura peaked around 5 years of age at 6.6/1,000 person-years; the peak for migraine without aura was 10/1,000 person-years between 10 and 11 years of age. New cases of migraine were uncommon in men in their twenties. In females, the incidence of migraine with aura peaked between ages 12 and 13 (14.1/1,000 person-years); migraine without aura peaked between ages 14 and 17 (18.9/1,000 person-years). Thus, migraine begins earlier in males than in females and migraine with aura begins earlier than does migraine without aura.
The published estimates of migraine prevalence have varied widely. In the greater Copenhagen study, for men, the lifetime prevalences were 93% for any kind of headache, 8% for migraine, and 69% for tension-type headache [5] . For women, the lifetime prevalences were 99% for all headache, 25% for migraine, and 88% for tension-type headache. The 1-year prevalence of migraine was 6% in men and 16% in women; the 1-year prevalence of tension-type headache was 63% and 86% respectively.
In the United States, the first American Migraine Study, based on data collected in 1989, used questionnaires mailed to 15,000 households selected to be representative of the US population [7] . Migraine diagnoses were based on the IHS criteria but headache duration and the lifetime number of previous migraine attacks were not considered. A follow-up study, the American Migraine Study II, used virtually identical methodology 10 years later and demonstrated very similar prevalence estimates [8] .
A meta-analytic summary of the prevalence studies show that prevalence increases throughout childhood and early adult life until approximately age 40, after which it declines ( Fig. 1) [3] .
The female-to-male migraine prevalence ratio also varies with age [3] . The onset of hormonal changes associated with menses may contribute to this variation. However, hormonal factors cannot be the sole cause; differences persist up to age 70 years and beyond, well beyond the time that cyclical hormonal changes can be considered a factor [10] .
Population studies show that individuals from highincome groups were much more likely to report a medical diagnosis of migraine than were those with lower income [11] . Perhaps migraine appears to be a disease of persons with high income in the doctor's office because high income individuals seek care.
Migraine prevalence also varies by race and geography. In the United States, it is highest in Caucasians, intermediate in African Americans, and lowest in Asian Americans [3] . Similarly, a meta-analysis of prevalence studies suggest that migraine is most common in North and South America, similar in Europe, but lower in Africa, and often lowest in studies from Asia (Fig. 2) [3] . The influence of reporting bias on these findings cannot be excluded. Nonetheless, the data suggest that race-related differences in genetic risk may contribute.
Individual burden of migraine
Migraine is a public health problem of enormous scope that has an impact on both the individual sufferer and on society [4] [5] [6] [7] [8] . The American Migraine Study II estimates that 28 million U.S. residents have severe migraine headaches [8] . Nearly one in four U.S. households has someone with migraine. Twenty-five percent of women in the United States who have migraine experience four or more severe attacks a month; 35% experience one to four severe attacks a month; 38% experience one, or less than one, severe attack a month [8] . Similar frequency patterns were observed for men [8] .
In the American Migraine Study II, 92% of women and 89% of men with severe migraine had some headache-related disability [8] . About half were severely disabled or needed bed rest [12] . In addition to the attack-related disability, many migraineurs live in fear, knowing that at any time an attack could disrupt their ability to work, care for their families, or meet social obligations. Abundant evidence indicates that migraine reduces health-related quality of life.
Societal impact of migraine
Migraine has an enormous impact on society. Recent U.S. studies have evaluated both the indirect costs of migraine as well as the direct costs [13] [14] [15] . Indirect costs include the aggregate effects of migraine on productivity at work (paid employment), in household work, and in other roles. The largest component of indirect costs is the productivity losses that take the form of absenteeism and reduced productivity while at work. Hu et al. estimated that productivity losses due to migraine cost American employers U.S. $13 billion per year [13] [14] [15] . These issues have been recently reviewed in more detail elsewhere [13] [14] [15] [16] .
The impact of migraine on healthcare utilization is marked as well. The National Ambulatory Medical Care Survey, conducted from 1976 to 1977, found that 4% of all Migraine is a lifelong disorder. Bille followed up a cohort of children with severe migraine for up to 37 years [18, 20] . As young adults, 62% were migraine-free for more than 2 years, but only 40% continued to be migraine-free after 30 years, suggesting that migraine is often a lifelong disorder.
Conclusions
Using the IHS criteria, large population-based epidemiological studies from most regions of the world have shed light on the descriptive epidemiology and burden of headache. While migraine is a remarkably common cause of temporary disability, many migraineurs, even those with disabling headache, have never consulted a physician for the problem. Prevalence is highest in women, in persons between the ages of 25 and 55 years, and, at least in the United States, in individuals from low-income households. Nonetheless, prevalence is high in groups other than these high-risk groups. Migraine prevalence may be increasing in the United States, but this has not been proven. Longitudinal studies are required to better determine the incidence and natural history of migraine as well as the life course of comorbid conditions.
